Invention Application
US20110130379A1 PIPERAZINE DERIVATIVES USED AS CAV2.2 CALCIUM CHANNEL MODULATORS
有权
用作CAV2.2钙通道调节剂的哌嗪衍生物
- Patent Title: PIPERAZINE DERIVATIVES USED AS CAV2.2 CALCIUM CHANNEL MODULATORS
- Patent Title (中): 用作CAV2.2钙通道调节剂的哌嗪衍生物
-
Application No.: US13054265Application Date: 2009-07-15
-
Publication No.: US20110130379A1Publication Date: 2011-06-02
- Inventor: Paul John Beswick , Alister Campbell , Andrew Peter Cridland , Robert James Gleave , Jag Paul Heer , Neville Hubert Nicholson , Lee William Page , Sadie Vile
- Applicant: Paul John Beswick , Alister Campbell , Andrew Peter Cridland , Robert James Gleave , Jag Paul Heer , Neville Hubert Nicholson , Lee William Page , Sadie Vile
- Applicant Address: GB Cambridge
- Assignee: CONVERGENCE PHARMACEUTICALS LIMITED
- Current Assignee: CONVERGENCE PHARMACEUTICALS LIMITED
- Current Assignee Address: GB Cambridge
- Priority: GB0813142.7 20080717
- International Application: PCT/EP2009/059011 WO 20090715
- Main IPC: A61K31/496
- IPC: A61K31/496 ; C07D401/06 ; A61P25/00 ; C07D401/14
Abstract:
The present invention relates to novel piperazine derivatives (I); to processes for their preparation; to pharmaceutical compositions containing the derivatives; and to the use of the derivatives in therapy to treat diseases for which blocking the Cav2.2 calcium channels is beneficial.
Public/Granted literature
- US08530478B2 Piperazine derivatives used as CAV2.2 calcium channel modulators Public/Granted day:2013-09-10
Information query
IPC分类:
